CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 64 filers reported holding CHEMOCENTRYX INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $610,470 | -77.5% | 35,700 | -82.4% | 0.01% | -70.6% |
| Q2 2021 | $2,712,734 | +574.8% | 202,594 | +1923.9% | 0.02% | +325.0% |
| Q1 2020 | $402,000 | -26.4% | 10,010 | -27.5% | 0.00% | 0.0% |
| Q4 2019 | $546,000 | +310.5% | 13,800 | -29.7% | 0.00% | +300.0% |
| Q3 2019 | $133,000 | -7.6% | 19,630 | +92.5% | 0.00% | -50.0% |
| Q2 2013 | $144,000 | – | 10,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |